AI Vivo
PrivateLast Round
Grant
Mar 24, 2026
Total Funding Raised
$103,000
Company Overview
AI Vivo is a biotechnology company that develops an AI-based proprietary pharmacology platform designed to capture the dynamic effect of diseases and treatments at the organ level to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Vivo Comparables
Compare AI Vivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 87% | |
| Pathway Bio | 86% | |
| CytoReason | 86% | |
AI Vivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 24, 2026 | ||||
| Accelerator | Nov 23, 2020 |
AI Vivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Seed |
| KQ Labs | Accelerator |
| Acequia Capital | Seed |
| o2h ventures | Seed |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Martlet Capital | Seed |
AI Vivo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AI Vivo's valuation, stock price, and market status.